Cargando…
Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. In the last 30 years several neuroprotective agents, attenuating the downstream molecular and cellular damaging events triggered by TBI, have been extensively studied. Even though many drugs have shown promising resul...
Autores principales: | Carbonara, Marco, Fossi, Francesca, Zoerle, Tommaso, Ortolano, Fabrizio, Moro, Federico, Pischiutta, Francesca, Zanier, Elisa R., Stocchetti, Nino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208094/ https://www.ncbi.nlm.nih.gov/pubmed/30405517 http://dx.doi.org/10.3389/fneur.2018.00885 |
Ejemplares similares
-
Rethinking Neuroprotection in Severe Traumatic Brain Injury: Toward Bedside Neuroprotection
por: Zoerle, Tommaso, et al.
Publicado: (2017) -
MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial
por: Zanier, Elisa R., et al.
Publicado: (2023) -
Systemic immune response in young and elderly patients after traumatic brain injury
por: Magatti, Marta, et al.
Publicado: (2023) -
Correction: Accuracy of Manual Intracranial Pressure Recording Compared to a Computerized High-Resolution System: A CENTER-TBI Analysis
por: Zoerle, Tommaso, et al.
Publicado: (2023) -
Accuracy of Manual Intracranial Pressure Recording Compared to a Computerized High-Resolution System: A CENTER-TBI Analysis
por: Zoerle, Tommaso, et al.
Publicado: (2023)